ℹ️ Observational Association Only Evidence
Analysis of national prescription claims found benzodiazepine prescribing declined from 2015 through 2019 before plateauing between 2020 and 2024. Despite overall reductions, long-term use remained common and dispensing increased in long-term care settings after 2020.
Clinical Considerations
- Benzodiazepine use declined from 14.1 to 11.5 per 100 persons between 2015 and 2019 before flattening.
- Nearly 24.9 million older adults filled at least one benzodiazepine prescription during the study period.
- Approximately one-third of users received long-term benzodiazepine therapy throughout the analysis.
- Adults aged 75 years and older experienced smaller prescribing reductions than younger older-adult cohorts.
Practice Applications
- Review chronic benzodiazepine therapy during routine medication assessments.
- Recognize persistent long-term utilization among adults aged 75 years and older.
- Monitor benzodiazepine use patterns in long-term care populations.
- Interpret prescribing trends alongside patient-specific risk-benefit considerations.
PATIENT EDUCATION
OBESITY/WEIGHT MANAGEMENT
EXERCISE/TRAINING
LEGAL MATTERS
GUIDELINES/RECOMMENDATIONS